TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

TTENK/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Options calculator
  • Leaderboards
  • Insider trades
  • 13F funds
  • Groups
  • Trending
  • News

More

  • Pricing
  • Feedback
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice.TENK is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities TENK rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. TENK/calls is an independent service and is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback

Pulling SEC filings + quote and writing the call…

TTENK/calls
The BriefMarketsAll StocksNewsScreenerFeedback
Home›LFST›Financials
Annual statements · SEC XBRL · FY2019 – FY2025

LifeStance Health Group, Inc. (LFST) financials

Income statement

LifeStance Health Group, Inc. (LFST) income statement, annual, from SEC filings
Fiscal yearFY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue$213M—$668M$860M$1.06B$1.25B$1.42B
Revenue growth———28.8%22.8%18.5%13.9%
Operating income$15.2M—-$286M-$210M-$189M-$31.6M$24.1M
Operating margin7.2%—-42.9%-24.5%-17.9%-2.5%1.7%
Net income$5.67M—-$307M-$216M-$186M-$57.4M$9.66M
Net margin2.7%—-46.0%-25.1%-17.6%-4.6%0.7%

Cash flow

LifeStance Health Group, Inc. (LFST) cash flow, annual, from SEC filings
Fiscal yearFY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow$17.0M—$9.42M$52.8M-$16.9M$107M$146M
Capital expenditures$14.3M—$94.5M$79.3M$40.5M$21.6M$36.1M
Free cash flow$2.73M—-$85.1M-$26.5M-$57.4M$85.7M$110M

Balance sheet

LifeStance Health Group, Inc. (LFST) balance sheet, annual, from SEC filings
Fiscal yearFY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash & equivalents$3.48M$18.8M$148M$109M$78.8M$155M$249M
Total assets—$1.57B$1.93B$2.17B$2.11B$2.12B$2.20B
Total liabilities—$537M$382M$655M$681M$672M$683M
Long-term debt—$363M$157M$225M$280M$280M$266M
Shareholders' equity-$166M$998M$1.55B$1.52B$1.43B$1.45B$1.52B
Retained earnings—-$13.1M-$357M-$573M-$761M-$818M-$809M
Shares (wtd avg diluted)——328K355M367M379M391M

Every figure is extracted from LifeStance Health Group, Inc.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.

Common questions

What is LifeStance Health Group, Inc.'s annual revenue?
LifeStance Health Group, Inc. (LFST) reported $1.42B of revenue for fiscal year 2025 — up 13.9% from $1.25B in FY2024, per its annual report filed with the SEC.
Is LifeStance Health Group, Inc. profitable?
Yes — LFST earned $9.66M of net income in FY2025, a 0.7% net margin, per SEC filings.
What is LifeStance Health Group, Inc.'s free cash flow?
$110M in FY2025 (operating cash flow $146M minus $36.1M of capital expenditures), from the SEC cash-flow statement.
Does LFST pay a dividend?
LifeStance Health Group, Inc. reported no cash dividends paid in FY2025, per its SEC cash-flow statement.
Full LFST analysis — verdict, score & filings →Is LFST a buy? →

Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.